In this ISSUE

FDA Examines Eligibility Criteria in Clinical Trial Design and Product Development

Clinical Trials Don't Have to Cost Too Much or Take Too Long

Is RBM living up to the hype? The state of RBM in clinical development
Wednesday, June 13, 2018 at 11am EDT
Register now

Blockchain Technology

Blockchain Concepts Emerge in Clinical Trials

In this interview, Munther Baara, Head of New Clinical Paradigms at Pfizer, will discuss his perspectives on how blockchain may impact clinical trials.
... /Read more/

The Future of ECOA
Tuesday, June 12, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Innovation

What's Behind the Clinical Innovation Gap?

Though digital technology has improved the R&D process, when it comes to important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs.
... /Read more/

Functional Service Models Reimagined: Integrating services and innovation for accelerated clinical development
Wednesday, June 6, 2018 at 11am EDT

Oncology

Oncology Therapy-Focused RACT Emerges

Newest revelations suggest Risk Assessment Categorization Tools are now becoming therapeutic area-specific, as an oncology-based risk library is now surfacing.
... /Read more/

Design of Early Phase Clinical Trials: How to Increase Efficiency and Probability of Success?
Europe: Tuesday, June 5, 2018 at 3pm CEST | 2pm BST
North America: Thursday, June 14, 2018 at 11am EDT | 10am CDT | 8am PDT

Calendar

/ BIO International Convention 6/4-6/7 /

/ 7th Annual Publication and Clinical Trial Transparency 6/20-6/21 /

American Pharma Outsourcing Summit 10/2-10/3 /

/ Crossroads: An Artia Solutions Conference 11/7-11/9 /

Operationalizing Gene Therapy Trials
On Demand

Learn more

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

Therapeutic Areas

BMS and Biomarker Research: An Interview with Saurabh Saha

BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
... /Read more/

Capturing The Attention of Investors: How to create a compelling value story
On Demand

Learn more

Clinical Trial Awarness

Awareness for Clinical Trials as a Care Option

May includes a number of events to get more visibility for clinical trial awareness, and to offer it as a care option.
... /Read more/

Considerations when Addressing the Challenges of Time, Cost, and Data Standardization in Clinical Trials
On Demand

website / blog / advertise / subscribe